临床试验/NCT01432392

NCT01432392已完成不适用

A Prospective, Observational Study to Describe Symptom Control and Impact on Daily Life in Patients With Gastroesophageal Reflux Disease (GERD)

AstraZeneca0 个研究点目标入组 1,000 人开始时间: 2011年9月最近更新: 2012年5月10日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方: AstraZeneca
入组人数: 1,000
主要终点: Percent change in intensity and frequency for each of typical GERD symptoms from baseline to week 4-6

研究概览研究设计入排标准结局指标研究者记录与标识符相似试验

研究概览

简要总结

The purpose of this study is to evaluate the impact of gastroesophageal reflux disease (GERD) treatment in primary care setting on symptom control and daily life in symptomatic GERD patients, using both GERD questionnaire and clinical symptoms assessment

详细描述

A prospective, observational study to describe symptom control and impact on daily life in patients with gastroesophageal reflux disease (GERD)

研究设计

研究类型: Observational
观察模型: Cohort
时间视角: Prospective

入排标准

年龄范围: 18 Years 至 —（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•Patients known or newly diagnosed with GERD
•Patients with typical GERD symptoms as heartburn and regurgitation for ≥2 days in the previous week
•Patients, currently not treated with a proton pump inhibitor

排除标准

•Patients who have been receiving treatment with non-steroidal antiinflammatory drugs within two weeks prior the inclusion in the study
•Patients with medical history of surgery of the esophagus, stomach or duodenum
•Pregnant or nursing females

结局指标

主要结局

Percent change in intensity and frequency for each of typical GERD symptoms from baseline to week 4-6

时间窗: Day 0 to week 4-6

Changes in GERD questionnaire(GERD-Q) scores from baseline to week 4-6

时间窗: Day 0 to week 4-6

次要结局

To evaluate the correlation between GERD-Q scores and symptom scores(two times)

研究者

发起方

AstraZeneca

申办方类型

Industry

责任方

Sponsor

相似试验

尚未招募

不适用

Thorcolumbar Kyphosis Patients With GERDthe GERD Occurence

NCT04521985National Taiwan University Hospital30

已完成

2 期

A Study to Assess the Efficacy, Safety and Tolerability of Tegaserod Alone and in Combination With Omeprazole Given Orally in Patients With Symptoms of Symptomatic Gastroesophageal Reflux Disease (sGERD)Symptomatic Gastroespohageal Reflux Disease

NCT00149851Novartis832

已完成

3 期

Efficacy Study of AGSPT201 Tablet to Treat Gastroesophageal Reflux DiseaseGastroesophageal Reflux Disease

NCT01400945Ahn-Gook Pharmaceuticals Co.,Ltd154

进行中（未招募）

不适用

Preserving the Pre-cardial Fat Pad During Sleeve Gastrectomy on Postoperative Gastroesophageal RefluxSleeve GastrectomyPre-cardial Fat PadExcessive Weight LossTotal Weight LossGastroesophageal Reflux Disease

NCT06732661Beijing Chao Yang Hospital50

已完成

不适用

An observational study for real world prescription patterns for the maintenance treatment of gastroesophageal reflux disease and survey on patient's preferenceDiseases of the digestive system

KCT0005810Yonsei University Health System, Gangnam Severance Hospital197